Bishop JL - Search Results

1

Salmonella: from pathogenesis to therapeutics.

Boyle EC, Bishop JL, Grassl GA, Finlay BB. Boyle EC, et al. Among authors: bishop jl. J Bacteriol. 2007 Mar;189(5):1489-95. doi: 10.1128/JB.01730-06. Epub 2006 Dec 22. J Bacteriol. 2007. PMID: 17189373 Free PMC article. Review. No abstract available.

2

Friend or foe? Antimicrobial peptides trigger pathogen virulence.

Bishop JL, Finlay BB. Bishop JL, et al. Trends Mol Med. 2006 Jan;12(1):3-6. doi: 10.1016/j.molmed.2005.11.001. Epub 2005 Nov 17. Trends Mol Med. 2006. PMID: 16298161

3

Deception point: peptidoglycan modification as a means of immune evasion.

Bishop JL, Boyle EC, Finlay BB. Bishop JL, et al. Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):691-2. doi: 10.1073/pnas.0611133104. Epub 2007 Jan 12. Proc Natl Acad Sci U S A. 2007. PMID: 17220274 Free PMC article. No abstract available.

4

The inositol phosphatase SHIP controls Salmonella enterica serovar Typhimurium infection in vivo.

Bishop JL, Sly LM, Krystal G, Finlay BB. Bishop JL, et al. Infect Immun. 2008 Jul;76(7):2913-22. doi: 10.1128/IAI.01596-07. Epub 2008 Apr 21. Infect Immun. 2008. PMID: 18426884 Free PMC article.

5

Lyn deficiency leads to increased microbiota-dependent intestinal inflammation and susceptibility to enteric pathogens.

Roberts ME, Bishop JL, Fan X, Beer JL, Kum WW, Krebs DL, Huang M, Gill N, Priatel JJ, Finlay BB, Harder KW. Roberts ME, et al. Among authors: bishop jl. J Immunol. 2014 Nov 15;193(10):5249-63. doi: 10.4049/jimmunol.1302832. Epub 2014 Oct 22. J Immunol. 2014. PMID: 25339668

6

SseL is a salmonella-specific translocated effector integrated into the SsrB-controlled salmonella pathogenicity island 2 type III secretion system.

Coombes BK, Lowden MJ, Bishop JL, Wickham ME, Brown NF, Duong N, Osborne S, Gal-Mor O, Finlay BB. Coombes BK, et al. Among authors: bishop jl. Infect Immun. 2007 Feb;75(2):574-80. doi: 10.1128/IAI.00985-06. Epub 2006 Dec 11. Infect Immun. 2007. PMID: 17158898 Free PMC article.

7

Targeting Prostate Cancer Subtype 1 by Forkhead Box M1 Pathway Inhibition.

Ketola K, Munuganti RSN, Davies A, Nip KM, Bishop JL, Zoubeidi A. Ketola K, et al. Among authors: bishop jl. Clin Cancer Res. 2017 Nov 15;23(22):6923-6933. doi: 10.1158/1078-0432.CCR-17-0901. Epub 2017 Sep 12. Clin Cancer Res. 2017. PMID: 28899970

8

A novel antiandrogen, Compound 30, suppresses castration-resistant and MDV3100-resistant prostate cancer growth in vitro and in vivo.

Kuruma H, Matsumoto H, Shiota M, Bishop J, Lamoureux F, Thomas C, Briere D, Los G, Gleave M, Fanjul A, Zoubeidi A. Kuruma H, et al. Mol Cancer Ther. 2013 May;12(5):567-76. doi: 10.1158/1535-7163.MCT-12-0798. Epub 2013 Mar 14. Mol Cancer Ther. 2013. PMID: 23493310

9

Molecular chaperone Hsp27 regulates the Hippo tumor suppressor pathway in cancer.

Vahid S, Thaper D, Gibson KF, Bishop JL, Zoubeidi A. Vahid S, et al. Among authors: bishop jl. Sci Rep. 2016 Aug 24;6:31842. doi: 10.1038/srep31842. Sci Rep. 2016. PMID: 27555231 Free PMC article.

10

An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer.

Davies A, Nouruzi S, Ganguli D, Namekawa T, Thaper D, Linder S, Karaoğlanoğlu F, Omur ME, Kim S, Kobelev M, Kumar S, Sivak O, Bostock C, Bishop J, Hoogstraat M, Talal A, Stelloo S, van der Poel H, Bergman AM, Ahmed M, Fazli L, Huang H, Tilley W, Goodrich D, Feng FY, Gleave M, He HH, Hach F, Zwart W, Beltran H, Selth L, Zoubeidi A. Davies A, et al. Nat Cell Biol. 2021 Sep;23(9):1023-1034. doi: 10.1038/s41556-021-00743-5. Epub 2021 Sep 6. Nat Cell Biol. 2021. PMID: 34489572 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83 results

Search Page